Allergy Therapeutics plc (AGY.L) LSE

8.35

+0.35(+4.38%)

Updated at September 08 04:35PM

Currency In GBp

Valuation

Market Cap175.94M
Enterprise Value194.01M
P/E Ratio-11.16
PEG Ratio-0.39
Price/Sales Ratio7.15
Price/Book Ratio-55.66
Enterprise/Revenue7.56
Enterprise/EBITDA-15.3

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.64
Operating Margin-0.54

Management Effectiveness

Return On Assets-0.49
Return On Equity20.72

Income Statement

Revenue55.2M
Revenue/Share0.01
Gross Profit29.74M
EBITDA-30.74M
Net Income-40.22M
Diluted EPS-0.01

Balance Sheet

Total Cash21.68M
Total Cash/Share0
Total Debt44.52M
Total Debt/Equity-6.23
Current Ratio1.6
Book Value Per Share-0

Price History

52-Week Change106.17
52-Week High9
52-Week Low3.8
Moving Average 50 Days8.25
Moving Average 200 Days7.08

Statistics

Average Volume327,786
Shares Outstanding4.77B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor63:29
Last Split DateSeptember 28, 2023